Dose intensity of nab-paclitaxel and gemcitabine chemotherapy in metastatic pancreatic cancer

被引：3
|
作者：
Lim, Alexander
Kim, Dae Won
Kim, Kunhwa
Kim, Richard D.
Bottiglieri, Salvatore Michael
机构：
[1] Univ S Florida, Dept Internal Med, Tampa, FL 33612 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.251
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
251
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
    Von Hoff, Daniel D.
    Ervin, Thomas
    Arena, Francis P.
    Chiorean, E. Gabriela
    Infante, Jeffrey
    Moore, Malcolm
    Seay, Thomas
    Tjulandin, Sergei A.
    Ma, Wen Wee
    Saleh, Mansoor N.
    Harris, Marion
    Reni, Michele
    Dowden, Scot
    Laheru, Daniel
    Bahary, Nathan
    Ramanathan, Ramesh K.
    Tabernero, Josep
    Hidalgo, Manuel
    Goldstein, David
    Van Cutsem, Eric
    Wei, Xinyu
    Iglesias, Jose
    Renschler, Markus F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (18): : 1691 - 1703
  • [32] Effect of Preoperative Nab-paclitaxel and Gemcitabine on Pancreatic Cancer Stroma
    Ishido, K.
    Kimura, N.
    Wakiya, T.
    Nagase, H.
    Odagiri, T.
    Mitsuhashi, Y.
    Goto, S.
    Yoshizawa, T.
    Kijima, H.
    Hakamada, K.
    PANCREAS, 2019, 48 (10) : 1451 - 1451
  • [33] Case report of nab-paclitaxel in metastatic pancreatic cancer
    Haslbauer F.
    memo - Magazine of European Medical Oncology, 2014, 7 (1) : 39 - 42
  • [34] Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine
    Di Costanzo, Francesco
    Di Costanzo, Federica
    Antonuzzo, Lorenzo
    Mazza, Ernesto
    Giommoni, Elisa
    CANCERS, 2023, 15 (02)
  • [35] The relationship between antitumor effects and relative dose intensity of gemcitabine plus nab-paclitaxel for unresectable pancreatic cancer.
    Ishigaki, Kazunaga
    Ozaka, Masato
    Kataoka, Seita
    Kanata, Ryo
    Yamada, Ikuhiro
    Sasaki, Takashi
    Matsuyama, Masato
    Takano, Kouichi
    Sasahira, Naoki
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [36] Exceptional Response to Second-Line Gemcitabine/Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Adenocarcinoma
    Bukhari, Nedal
    Abdalla, Khalda
    Ibnshamsa, Fahad
    Alselwi, Waleed
    Al-Shakir, Shakir
    Alqahtani, Mohammed
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [37] Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
    Sezgin, Yasin
    Karhan, Ogur
    Aldemir, Mehmet Naci
    Urun, Muslih
    Ercek, Berrak Mermit
    Urakci, Zuhat
    Arvas, Hayati
    Tunc, Sezai
    Erdem, Mehmet
    Yerlikaya, Halis
    Ileri, Serdar
    Aydin, Ibrahim
    Bicer, Abdurrahman
    Komuroglu, Ahmet Ufuk
    Majidova, Nargiz
    Gokcek, Savas
    Demir, Hacer
    Yildiz, Sedat
    Akbas, Sinem
    Ozen, Esra
    Kahya, Burcu Ulas
    Sali, Muersel
    Anik, Hicran
    Aykut, Talat
    Araz, Murat
    Alkan, Ali
    Ozcelik, Melike
    Sakin, Abudllah
    Aykan, Musa Baris
    Mehtiyev, Mirmehdi
    Demir, Bilgin
    Baser, Mehmet Nuri
    Sonmez, Muge
    Gulturk, Ilkay
    Avci, Niluever
    Urvay, Semiha
    Arici, Mustafa Ozgur
    Kalender, Mehmet Emin
    Yildirim, Mustafa
    Solmaz, Ali Alper
    Gurbuz, Mustafa
    Ergun, Yakup
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [38] A cost-utility analysis of gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer.
    Ko, Yoo-Joung
    Tam, Vincent Channing
    Mittmann, Nicole
    Pasteka, Mark
    Chan, Kelvin K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] Phase II study of pirfenidone combined with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer
    Guo, Guifang
    Li, Shengping
    Mao, Yize
    Yang, Qiuxia
    Yao, Zehui
    Wang, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Phase II trial of biologically optimized schedule of gemcitabine and nab-paclitaxel in metastatic pancreatic cancer
    Noonan, Anne M.
    Noonan, Anne M.
    Abushahin, Laith I.
    Wei, Lai
    Malalur, Pannaga G.
    Manne, Ashish
    Mittra, Arjun
    Roychowdhury, Sameek
    Jin, Ning
    Hays, John L.
    Babcook, Melissa A.
    Risch, Zachary
    Rahman, Shafia
    Hazard, Brooke
    Williams, Terence Marques
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345